We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Primate Studies to Evaluate TGF-Alpha for Parkinson's

By Biotechdaily staff writers
Posted on 30 Sep 2002
Primate studies to evaluate the potential of transforming growth factor alpha (TGF-alpha) to treat Parkinson's disease are being conduced by researchers at the Surgical Neurology Branch of the US National Institutes of Health (Bethesda, MD, USA).

The studies are focused on analyzing the proliferative effect of TGF-alpha on brain stem cells in those critical regions of the brain affected by Parkinson's disease, as well as defining drug delivery parameters in anticipation of human trials. More...
TGF-alpha will be delivered to the primates using convection-enhanced drug delivery (CED), designed to ensure optimal delivery of the drug to bodily tissues, including the brain.

"Preliminary studies in animal models have shown substantial promise for TGF-alpha for the treatment of Parkinson's disease,” said Dr. Edward Oldfield, chief of the Surgical Neurology Branch and leader of the study. CED delivery was developed in Dr. Oldfield's laboratory.

The study will use a proprietary compound of TGF-alpha produced by Kaleidos Pharma, Inc. (Seattle, WA, USA), under a special agreement with the company. TGF-alpha was originally discovered by Dr. George Todaro, of the US National Academy of Sciences, and Dr. Daniel Twardzik, vice president, research, at Kaleidos Pharma. Studies have shown that TFG-alpha causes replacement of lost nerve cells and reverses symptoms in an established animal model of Parkinson's disease.




Related Links:
National Institutes of Health

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
POC Immunoassay Analyzer
Procise DX
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.